Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carboxylesterase 2 (CES2) is an enzyme primarily involved in the hydrolysis of ester and amide bonds. It plays a crucial role in drug and lipid metabolism, as well as detoxification. CES2 is highly expressed in the liver, intestine, and kidney and is implicated in various diseases, including NAFLD and certain cancers. Genetic polymorphisms in CES2 can affect drug response.
Hydrolyzes ester and amide bonds in drugs and endogenous compounds, affecting their bioavailability and activity.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carboxylesterase 2 (CES2).